相关实验视频

Updated: Jun 7, 2025

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

人类iPSC中的NDUFS4的CRISPR-Cas9中介淘汰:线粒体复合体I缺乏症的一个模型

Shivani Goolab¹, Karin Terburgh², Charl du Plessis²

¹Bioengineering and Integrated Genomics Group, Future Productions: Chemicals Cluster, Council for Scientific and Industrial Research, Pretoria, South Africa.

Biochimica et biophysica acta. Molecular basis of disease

|November 15, 2024

概括

我们开发了一种新的诱导多能干细胞 (iPSC) 模型,用于NDUFS4相关的复合I缺乏症,一种线粒体疾病. 这种模型显示了代谢变化,可以帮助选线粒体功能障碍的药物.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
遗传学遗传学是一个

背景情况:

线粒体疾病,特别是复杂I (CI) 缺陷,缺乏有效的治疗方法.
诱导多能干细胞 (iPSCs) 为疾病建模和药物发现提供了一个有希望的平台.
NDUFS4基因缺陷是CI缺陷的已知原因之一.

研究的目的:

创建和描述一个与NDUFS4相关的CI缺陷的新型人类iPSC模型.
为了研究这些iPSCs的代谢表型.
评估iPSCs在治疗化合物的高通量选方面的潜力.

主要方法:

在CRISPR-Cas9基因编辑中生成NDUFS4淘汰赛 (KO) iPSCs.
桑格测序和西方抹杀用于遗传和蛋白质验证.
酶动力学测试用于测量CI活性.
代谢概况分析用于分析细胞代谢.
用β-拉帕治疗以评估治疗效果.

主要成果:

确立的同位体NDUFS4KO iPSC线条与确认的NDUFS4删除和~56%降低CI活性.
在KO iPSC中观察到明显的代谢表型,包括较高的NADH/NAD+比率.
证明β-lapachone可以减轻KO iPSCs中的减小压力.

结论:

新的iPSC模型准确地反映了NDUFS4相关CI缺陷的关键代谢变化.
这种iPSC模型为线粒体功能障碍的早期,高通量药物查提供了宝贵的工具.
iPSCs为探索线粒体疾病的治疗策略提供了一个相关的代谢环境.

关键词:

缺少CI的缺陷是CI的缺陷克里斯普尔-Cas9是什么意思线粒体疾病线粒体疾病这就是 iPSC 的意义.

更多相关视频

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

Published on: November 1, 2024

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System

Published on: November 8, 2017

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.